The demand for COVID-19 tests in drugstores throughout Brazil has increased by 44% within a two-week period, according to the Brazilian Pharmacy and Drugstore Chains Association (Abrafarma). This rise occurs at the same time as the flu outbreak caused by the virus.

Between December 13 and 19, 137,618 people have made a COVID-19 test, which represents an increase of 9% compared to the period between December 6 and 12. In relation to the period from November 29 to December 5, however, the increase had reached 44%. The average of testing in drugstores, according to the association, had been falling since June, but it has started to rise again in the last two months.

Out of the 137,618, 10,982 people have tested positive for COVID-19, and in the previous week 8,278. The percentage of coronavirus diagnoses, in relation to the total number of people who have made the test, has increased from 6.56% to 7.98%. But, according to the survey, “if one considers the daily average of cases, the figure shows a downward trend.”

Abrafarma incorporates the 26 largest drugstore chains in Brazil, totaling more than 8,500 stores in all states and the Federal District. The association points out that it represents about 45% of the drug sales in the country.

According to data from December 30 from the Ministry of Health, 13,405 new cases and 167 deaths have been registered in the last 24 hours.

Source: Agência Brasil